Skip to main content
search
Poster

PBPK Modelling of Bispecific Monoclonal Antibody Tumour Targeting Specificity

Skip to PDF content

Author: Armin Sepp (Certara UK Ltd., Simcyp Division)

Supporting PBPK applications across drug development

Simcyp offers a comprehensive suite of PBPK modeling solutions. Learn how Simcyp can support your MIDD strategies.

Learn more about Simcyp:

You May Also Like

Sex-Specific Bioequivalence Outcomes: PBPK Insights into Gastric Emptying Variability
Sex-Specific Bioequivalence Outcomes: PBPK Insights into Gastric Emptying VariabilityPoster

Sex-Specific Bioequivalence Outcomes: PBPK Insights into Gastric Emptying Variability

PBPK Modelling of Formulation-Dependent Food Effects for Itraconazole Oral Solution
PBPK Modelling of Formulation-Dependent Food Effects for Itraconazole Oral SolutionPoster

PBPK Modelling of Formulation-Dependent Food Effects for Itraconazole Oral Solution

Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal Antibodies
Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal AntibodiesPoster

Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal Antibodies